Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-BRG1 antibody [EPR3912] - BSA and Azide free (ab222230)

Publishing research using ab222230? Please let us know so that we can cite the reference in this datasheet.

ab222230 has been referenced in 1 publication.

  • Vangamudi B  et al. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies. Cancer Res 75:3865-78 (2015). PubMed: 26139243

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up